Increased antiandrogen enzalutamide sensitivity via altering prostate cancer stem cell traits through modulating the androgen receptor-mediated CDR1/circCDR1-AS/miR-1290/BMP4 signaling

Diwei Huo(Harbin Medical University), Keliang Wang(Harbin Medical University), Xiujie Chen(Harbin Medical University), Jinguo Li(Chinese Academy of Sciences), Xunwei Wang(Harbin Medical University), Ronghui Xu(University of California, San Diego), Ke‐Xin Yu(Harbin Medical University), Yongfeng Du(Harbin Medical University), Pengbo Li(Shandong Provincial Hospital), Zhengxing Chen(Harbin Medical University), X. Su(Harbin Medical University), Minggui Si(Harbin Medical University), Huike Yang(Harbin Medical University), Hongbo Liu(Hebei University of Engineering), D P Li(Harbin Medical University), Xuebin Ma(Harbin Medical University), Xiaoxue Fang(Changchun University of Chinese Medicine)
Oncogene
July 4, 2025
Cited by 2


Related Papers